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Chordoma arises from cellular remnants of the notochord. It is the most common primary malignancy of the spine in 
adults. Approximately 50% of chordomas arise from the sacrococcygeal area with other areas of the spine giving rise 
to another 15% of chordomas. Following complete resection, patients can expect a 5-year survival rate of 85%. Chordoma 
has a recurrence rate of 40%, which leads to a less favorable prognosis. Here, we report two cases of chordoma presenting 
with occipital neuralgia and cervicalgia. The first patient presented with a C1-C2 chordoma. He rejected surgical inter-
vention and ultimately died of respiratory failure. The second patient had an atlantoaxial chordoma and underwent 
surgery because of continued occipital neuralgia and cervicalgia despite nerve block. This patient has remained symp-
tom-free since his operation. The presented cases show that the patients’ willingness to participate in treatment can 
lead to appropriate and aggressive management of cancer pain, resulting in better outcomes in cancer treatment. 
Key Words: Atlantoaxial, Chordoma, Occipital, Neuralgia, Block
Received: August 22, 2014, Accepted: September 5, 2014
*Corresponding author: Woo Young Park
Department of Anesthesiology and Pain Medicine, Yonsei University 
Wonju College of Medicine, 20 Ilsan-ro, Wonju 220-701, Republic of 
Korea
Tel: 82-33-741-1521, Fax: 82-33-742-8198
E-mail: ulung@yonsei.ac.kr
Case Report
Vol. 4, No. 2, 104-108
http://dx.doi.org/10.15280/jlm.2014.4.2.104
INTRODUCTION
Chordoma originates from the cellular remnants of the 
notochord. It is the most common primary malignancy of 
the spine in adults, and is typically seen in adolescents and 
young and middle-aged adults. Approximately 50% of chor-
domas originate from the sacrococcygeal area. Other areas 
of the spine give rise to another 15% of chordomas [1]. The 
5-year survival rate is 85% in patients with complete 
resection. Chordomas have a recurrence rate of 40%. With 
recurrence, a secondary surgery becomes necessary, how-
ever, recurrence portends a poor prognosis even with addi-
tional radiotherapy and chemotherapy [2]. Additional treat-
ments can lead to general weakness because of a longer du-
ration of treatment, and cancer pain can be a threat to qual-
ity of life. We report on two patients with chordoma that 
presented with occipital neuralgia and cervicalgia. The first 
patient had a C1-C2 vertebral body chordoma that was di-
agnosed at another center. The patient refused surgical re-
section and, despite pain management and nerve block, ulti-
mately succumbed to death. The second case presented with 
sustained occipital neuralgia and cervicalgia unresponsive to 
nerve block. Following MRI imaging and diagnosis, the pa-
tient underwent surgery and remained symptom-free. The 
presented cases have different outcomes and prognoses 
stemming from the difference in intensive surgical manage-
ment and pain control.
CASE REPORT
1. Case Report 1
A 71-year-old man was referred to our pain clinic with 
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Fig. 1. Sagittal and axial T2-wei-
ghted MRI image of atlantoaxial 
chordoma in case 1. It shows da-
maged bony structures and soft 
tissue invasion. Arrow points to 
the chordoma mass.
the complaint of persistent occipital neuralgia. Three months 
before his presentation, he had undergone transoral biopsy 
and subtotal removal of a large retropharyngeal tumor. In 
the computed tomography (CT) imaging, the tumor was 
seen in the cervical spine, and further magnetic resonance 
imaging (MRI) studies identified the tumor around the first 
and second cervical vertebrae (Fig. 1). During a clinic visit, 
the patient was alert and primarily complained of right-sid-
ed occipital headache. Additionally, the patient complained 
of generalized weakness, fatigue, poor intake, and sleep 
disturbance. His headache was described as being persistent 
and not changing with position. The right-sided occipital 
pain was 6-7 on the visual analogue scale (VAS) score. He 
also had breakthrough pain occurring 2-3 times everyday 
that was determined to be of 7-8 severity on the VAS score. 
He was given tramadol hydrochloride 37.5 mg, acet-
aminophen 325 mg, prednisolone 5 mg, diazepam 2 mg, and 
fentanyl patch 25 mg/h. For the control of breakthrough 
pain, he was given IR-codon 5 mg as needed. Right occipital 
nerve block was performed five times during his 13-day ad-
mission, and the fentanyl patch dose was increased to 50 
mcg/h. With these treatment measures, his pain decreased 
to 2-3 on the VAS score with reduction of breakthrough 
pain to 1-2 times a day. After discharge, an occipital nerve 
block was performed once a week for 2 months, and his 
VAS scored remained 4-6. The patient refused surgical re-
moval of the spinal tumor and radiotherapy. Therefore, he 
was kept on his existing medications. On 4-month follow-up 
imaging, we found that the cervical spinal tumor had in-
creased in size. After 6 months of follow-up, the patient 
was admitted to our institution’s intensive care unit because 
of pain and drowsiness, and ultimately passed away due to 
respiratory failure. 
2. Case Report 2
A 75-year-old man with the chief complaint of neck pain 
and tingling in his upper extremities was referred to our in-
stitution’s pain clinic. On physical examination, his upper 
extremities had normal motor function but the left thumb 
and index finger had diminished sensation. There was ten-
derness on the back of the neck. Bilateral occipital cervi-
calgia was 7-8 on the VAS score. The patient also com-
plained of a persistent and dull pain in his left shoulder. 
To control his neck pain, a cervical epidural block was per-
formed at the C6-C7 level using a mixture of mepivacaine 
0.5% 5 mL and dexamethasone 2 mg. Despite the block, oc-
cipital cervicalgia persisted, and an MRI was performed. In 
cervical spine MRI images, atlantoaxial bony fragmentation 
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Fig. 2. Sagittal and axial T1-wei-
ghted MRI image of atlantoaxial 
chordoma in case 2. It shows at-
lantoaxial bony fragmentation and
a soft tissue mass in the epidural 
and prevertebral spaces. Arrow 
points to the chordoma mass.
and a soft tissue mass in the epidural and prevertebral spaces 
was identified. In addition, left lateral canal stenosis was ob-
served between the second and third cervical vertebrae and 
between the seventh cervical and the first thoracic vertebrae 
(Fig. 2). Over 15 days after discharge, a cervical epidural 
block, bilateral occipital nerve block, and left supra-
clavicular nerve block were performed. In addition, the pa-
tient was given tramadol hydrochloride 37.5 mg b.i.d. and 
acetaminophen 325 mg b.i.d. After these treatments, the pa-
tient had a VAS score of 3-4. The patient was referred to 
another hospital to receive cervical spine surgery and under-
went tumor excision of the second cervical spine and poste-
rior C1-C2 fixation. The mass was pathologically confirmed 
as chordoma. The patient’s neck pain and tingling dis-
appeared after the surgery.
DISCUSSION
Chordoma is a relatively rare tumor that primarily occurs 
in the axial skeleton. Approximately 6% of chordomas arise 
from the cervical spine as a slowly growing tumor, which 
makes the tumor symptomatic at relatively later stages [3,4]. 
Upper cervical tumors often are accidentally discovered 
during investigation of cervical radiculopathy. The tumor 
causes compression of the cervical nerve roots or gives rise 
to referred pain in the neck due to invasion into the cervical 
facet joints. Occasionally, the lesion is mistaken for a facet 
joint pathology or cervical disc herniation. It also can create 
a mass effect in the retropharyngeal area and cause symp-
toms such as dysphagia and dysphonia [4,5]. There is a 
5-43% rate of metastasis to lung and other spinal areas. 
Although the tumor is histologically benign, it is clinically 
malignant as it infiltrates the neighboring tissues, such as 
bone, lymph nodes, skin, liver, and brain [6].
Gadolinium-enhanced MRI imaging shows heterogeneous 
lesions with low- to moderate- signal intensities on T1-wei-
ghted images and high-signal intensities on T2-weighted im-
ages [7,8]. Definitive diagnosis of chordoma requires histo-
logic evaluation in which physaliferous cells with cytoplas-
mic vacuoles and positive periodic acid-Schiff (PAS) stain-
ing are observed [9].
The prognosis of chordoma is significantly affected by 
the first operation; the chance of clinical resolution dimin-
ishes with recurrence even with additional treatments. In 
surgery, en-bloc resection with cancer-free margins ensures 
long-term survival [10]. If en-bloc resection is not possible, 
adjuvant radiotherapy is used to remove remnant parts of 
the tumor. Palliative care of chordoma includes sympto-
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Fig. 3. Ultrasound image of the right greater occipital nerve. 
GON: greater occipital nerve.
matic treatment, palliative surgery, radiotherapy, and post-
operative local chemotherapy with cisplatin on the resected 
margins [11]. In cases with recurrence or incomplete re-
section, pain control lets the patients return to their previous 
daily activities and reinforces their willingness to partake in 
treatment and rehabilitation [12].
Atlantoaxial chordoma frequently becomes clinically 
symptomatic when it has grown considerably in size. Nerve 
compression and intraspinal invasion may result in severe 
neurologic complications [13]. In our presented cases, the 
tumor had invaded the second cervical spine root, and neu-
ralgia of the greater occipital nerve led to headache. 
Occipital neuralgia develops when the atlantoaxial chordo-
ma invades the second cervical spinal nerve root or com-
presses neighboring tissues. When the mass invades the at-
lanto-occipital joint or the zygapophysial joint of the second 
and third cervical vertebrae, referred pain is experienced in 
the lower occipital and posterior upper cervical areas. If the 
symptoms persist without appropriate treatment, they may 
progress to neuropathy. Once the neuralgia becomes a neu-
ropathy, symptoms may persist despite tumor resection. 
Pain management is affected by tumor involvement. The 
tumor is frequently covered with a capsule and causes a de-
viation in the vertebral artery and nerve roots to disrupt the 
normal anatomy, which makes transforaminal epidural ap-
proaches and root block procedures difficult. We had a mul-
timodal approach for pain management via ultrasound- 
guided greater occipital nerve block, and an interlaminar 
approach for cervical epidural block and medications. The 
second cervical nerve originates between the first and sec-
ond cervical vertebrae. The medial branch of the dorsal pri-
mary ramus joins the medial branch of the third cervical 
nerve underneath the inferior obliquus capitis muscle to 
form the occipital nerve. Then, it surrounds the suboccipital 
triangle and runs upward. After penetration of the trapezius 
muscle, the occipital nerve innervates the skin on the poste-
rior parts of the scalp and vertex [14]. The greater occipital 
nerve runs upward through the trapezius muscle and 2 cm 
lateral to the occipital artery and 2 cm inferior to the inion.
Ultrasound-guided greater occipital nerve block is a more 
precise procedure that requires less local anesthesia (Fig. 3). 
It also prevents complications such as arterial puncture or 
nerve injury [15]. In our patients, we achieved acceptable 
results of pain relief using multimodal pain management 
that included ultrasound-guided occipital nerve block. Our 
patients had atlantoaxial chordoma and suffered from occi-
pital neuralgia due to compression of the second cervical 
ganglion. The first presented patient gave up aggressive pain 
control and, with aggravation of symptoms, loss of willing-
ness to participate in treatment was evident. Along with the 
refusal to have a surgical resection, suffering from pain sig-
nificantly reduced quality of life in this patient. In contrast, 
the other patient had a successful surgical resection and ag-
gressive pain management, which led to reinforcement of 
his willingness to continue treatment and this increased his 
quality of life. 
In conclusion, the presented cases show that the patients’ 
willingness to participate in treatment can lead to appro-
priate and aggressive management of cancer pain, resulting 
in better outcomes in cancer treatment. 
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